Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Applovin
APP
|
+$810M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$748M |
| 3 |
Palantir
PLTR
|
+$504M |
| 4 |
Union Pacific
UNP
|
+$391M |
| 5 |
AbbVie
ABBV
|
+$366M |
Top Sells
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.88B |
| 2 |
Meta Platforms (Facebook)
META
|
+$719M |
| 3 |
Broadcom
AVGO
|
+$683M |
| 4 |
Bank of America
BAC
|
+$675M |
| 5 |
Wells Fargo
WFC
|
+$631M |
Sector Composition
| 1 | Technology | 16.39% |
| 2 | Financials | 13.7% |
| 3 | Healthcare | 12.33% |
| 4 | Industrials | 11.64% |
| 5 | Consumer Discretionary | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
N-able
NABL
$1.55B
| $4.92M | ﹤0.01% |
607,755
+503,393
| +482% | +$4.08M |
|
2002
Gold Royalty Corp
GROY
$640M
| $4.91M | ﹤0.01% |
2,223,226
+1,603,953
| +259% | +$3.54M |
|
2003
Ocugen
OCGN
$369M
| $4.91M | ﹤0.01% |
5,058,926
+4,977,618
| +6,122% | +$4.83M |
|
2004
Metals Acquisition
MTAL
$1.01B
| $4.88M | ﹤0.01% |
403,563
+283,331
| +236% | +$3.43M |
|
|
CMPS
2005
Compass Pathways
CMPS
$492M
| $4.88M | ﹤0.01% |
1,741,782
-1,031,739
| -37% | -$2.89M |
|
2006
Douglas Emmett
DEI
$2.77B
| $4.87M | ﹤0.01% |
323,728
+45,659
| +16% | +$687K |
|
|
TGB
2007
Taseko Mines
TGB
$1.15B
| $4.86M | ﹤0.01% |
1,543,528
+924,410
| +149% | +$2.91M |
|
2008
3D Systems Corporation
DDD
$291M
| $4.86M | ﹤0.01% |
3,154,563
+1,535,036
| +95% | +$2.36M |
|
2009
Allegion
ALLE
$15.2B
| $4.85M | ﹤0.01% |
33,630
-161,103
| -83% | -$23.2M |
|
2010
SPDR S&P MidCap 400 ETF Trust
MDY
$24B
| $4.84M | ﹤0.01% |
8,551
-93,560
| -92% | -$53M |
|
|
VRE
2011
Veris Residential
VRE
$1.44B
| $4.84M | ﹤0.01% |
325,270
-1,173,636
| -78% | -$17.5M |
|
2012
Symbotic
SYM
$5.7B
| $4.83M | ﹤0.01% |
124,426
-311,141
| -71% | -$12.1M |
|
2013
Nomura Holdings
NMR
$22.1B
| $4.83M | ﹤0.01% |
733,981
+96,192
| +15% | +$633K |
|
2014
Iris Energy
IREN
$9.53B
| $4.83M | ﹤0.01% |
331,433
+313,199
| +1,718% | +$4.56M |
|
2015
Erasca
ERAS
$448M
| $4.82M | ﹤0.01% |
3,797,987
+573,469
| +18% | +$728K |
|
2016
Emergent Biosolutions
EBS
$427M
| $4.82M | ﹤0.01% |
755,432
-1,747,056
| -70% | -$11.1M |
|
2017
CAVA Group
CAVA
$7.28B
| $4.81M | ﹤0.01% |
57,059
-337,688
| -86% | -$28.4M |
|
2018
Brighthouse Financial
BHF
$2.71B
| $4.79M | ﹤0.01% |
89,024
-173,866
| -66% | -$9.35M |
|
2019
1-800-Flowers.com
FLWS
$344M
| $4.78M | ﹤0.01% |
972,367
+937,041
| +2,653% | +$4.61M |
|
2020
Banc of California
BANC
$2.61B
| $4.77M | ﹤0.01% |
339,656
-3,294,935
| -91% | -$46.3M |
|
2021
BRF SA
BRFS
$6.31B
| $4.77M | ﹤0.01% |
1,307,192
-4,327,356
| -77% | -$15.8M |
|
2022
Hillman Solutions
HLMN
$1.93B
| $4.76M | ﹤0.01% |
666,458
+136,854
| +26% | +$977K |
|
|
ITOS
2023
DELISTED
iTeos Therapeutics
ITOS
| $4.76M | ﹤0.01% |
477,189
+128,830
| +37% | +$1.28M |
|
2024
Select Medical
SEM
$1.52B
| $4.75M | ﹤0.01% |
313,106
-1,399,885
| -82% | -$21.3M |
|
2025
Sable Offshore Corp
SOC
$2.23B
| $4.74M | ﹤0.01% |
215,820
+197,619
| +1,086% | +$4.34M |
|